2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial.

Mohamed Amine M, Selma M, Adel S, Khaoula BHA, Mohamed Hassene K, Imen T, Ahmed A, Nadia BB, Yosra BD, Rabie R, Mohamed Habib G, Kaouthar B, Mehdi M, Asma B, Wahid B, Riadh B, Hamdi B, Semir N, GREAT Network

Open source

DOI: 10.1371/journal.pone.0251716
Published: 2021
Container: PloS one
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0251716,
  title = {2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial.},
  author = {Mohamed Amine M and Selma M and Adel S and Khaoula BHA and Mohamed Hassene K and Imen T and Ahmed A and Nadia BB and Yosra BD and Rabie R and Mohamed Habib G and Kaouthar B and Mehdi M and Asma B and Wahid B and Riadh B and Hamdi B and Semir N and GREAT Network},
  year = {2021},
  journal = {PloS one},
  doi = {10.1371/journal.pone.0251716},
  url = {https://doi.org/10.1371/journal.pone.0251716}
}

RIS

TY  - JOUR
TI  - 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial.
AU  - Mohamed Amine M
AU  - Selma M
AU  - Adel S
AU  - Khaoula BHA
AU  - Mohamed Hassene K
AU  - Imen T
AU  - Ahmed A
AU  - Nadia BB
AU  - Yosra BD
AU  - Rabie R
AU  - Mohamed Habib G
AU  - Kaouthar B
AU  - Mehdi M
AU  - Asma B
AU  - Wahid B
AU  - Riadh B
AU  - Hamdi B
AU  - Semir N
AU  - GREAT Network
PY  - 2021
JO  - PloS one
DO  - 10.1371/journal.pone.0251716
UR  - https://doi.org/10.1371/journal.pone.0251716
ER  -

APA

M, M. A., M, S., S, A., BHA, K., K, M. H., T, I., A, A., BB, N., BD, Y., R, R., G, M. H., B, K., M, M., B, A., B, W., B, R., B, H., N, S., & Network, G. (2021). 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial.. PloS one. https://doi.org/10.1371/journal.pone.0251716

Source records

pubmed · retrieved 2026-09-25T08:10:29.174Z